Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	retinoic acid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.28e-05	28	141	4	GO:0001972
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.05e-04	35	141	4	GO:0015020
GeneOntologyMolecularFunction	retinoid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.64e-04	48	141	4	GO:0005501
GeneOntologyMolecularFunction	isoprenoid binding	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.94e-04	49	141	4	GO:0019840
GeneOntologyBiologicalProcess	estrogen catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.07e-08	5	142	4	GO:0006711
GeneOntologyBiologicalProcess	phenylpropanoid catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.20e-08	6	142	4	GO:0046271
GeneOntologyBiologicalProcess	coumarin catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.20e-08	6	142	4	GO:0046226
GeneOntologyBiologicalProcess	flavone metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.20e-08	6	142	4	GO:0051552
GeneOntologyBiologicalProcess	steroid catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9 HSD3B7 SCARB1	1.10e-07	34	142	6	GO:0006706
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-07	10	142	4	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.38e-07	10	142	4	GO:0009804
GeneOntologyBiologicalProcess	flavonoid metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.47e-06	13	142	4	GO:0009812
GeneOntologyBiologicalProcess	flavonoid glucuronidation	UGT1A8 UGT1A7 UGT1A9	3.16e-06	5	142	3	GO:0052696
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.18e-05	21	142	4	GO:0052695
GeneOntologyBiologicalProcess	hormone catabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.18e-05	21	142	4	GO:0042447
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.86e-05	26	142	4	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.86e-05	26	142	4	GO:0006063
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT1A8 UGT1A7 UGT1A9	6.72e-05	12	142	3	GO:0052697
GeneOntologyBiologicalProcess	central nervous system development	SOX5 CACNA1A NDST1 ABCA2 ARHGEF28 ZNF148 ATG7 ENPP2 CA10 FANCD2 C2CD3 EGF PTPRZ1 GLI3 BRINP2 MIOS SMG9 LRP6 HYDIN PCNT NPAS1	7.14e-05	1197	142	21	GO:0007417
GeneOntologyBiologicalProcess	positive regulation of protein tyrosine kinase activity	ABI1 NEDD9 EGF ABI2	9.55e-05	35	142	4	GO:0061098
GeneOntologyBiologicalProcess	axis elongation	TNC TMTC3 HOXD13 LRP6	1.33e-04	38	142	4	GO:0003401
GeneOntologyBiologicalProcess	animal organ morphogenesis	TBX15 SOX5 ADAMTS19 NDST1 XIRP1 CDX2 TBX4 TNC LAMA2 LAMA3 ACTG2 SLC4A2 FANCD2 C2CD3 TMTC3 XIRP2 HOXD13 ABI2 GLI3 LRP6 PCNT	1.62e-04	1269	142	21	GO:0009887
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	TANC2 CACNA1A ABI1 ARHGEF28 ATG7 CDHR1 TRPC5 LAMA2 LAMA3 ANKRD27 CELSR3 ABI2 PTPRZ1 GLI3 POTEJ	2.05e-04	748	142	15	GO:0048667
GeneOntologyBiologicalProcess	neural precursor cell proliferation	SOX5 ZZEF1 EGF PTPRZ1 GLI3 MIOS LRP6 PCNT	2.15e-04	233	142	8	GO:0061351
GeneOntologyBiologicalProcess	bud outgrowth involved in lung branching	TNC TMTC3	2.80e-04	4	142	2	GO:0060447
GeneOntologyBiologicalProcess	oligodendrocyte differentiation	SOX5 ABCA2 ENPP2 PTPRZ1 GLI3 MIOS	3.76e-04	137	142	6	GO:0048709
GeneOntologyBiologicalProcess	branch elongation of an epithelium	TNC TMTC3 HOXD13	4.47e-04	22	142	3	GO:0060602
GeneOntologyBiologicalProcess	peptidyl-tyrosine phosphorylation	ABI1 ENPP2 DYRK1A ZZEF1 NEDD9 EGF ABI2 BST1 PTPRZ1	4.48e-04	327	142	9	GO:0018108
GeneOntologyBiologicalProcess	dendrite morphogenesis	TANC2 CACNA1A ABI1 TRPC5 ANKRD27 ABI2 PTPRZ1	4.51e-04	198	142	7	GO:0048813
GeneOntologyBiologicalProcess	estrogen metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.51e-04	52	142	4	GO:0008210
GeneOntologyBiologicalProcess	peptidyl-tyrosine modification	ABI1 ENPP2 DYRK1A ZZEF1 NEDD9 EGF ABI2 BST1 PTPRZ1	4.68e-04	329	142	9	GO:0018212
GeneOntologyBiologicalProcess	pigment metabolic process	UGT1A10 UGT1A8 UGT1A7 UGT1A9 UROS	4.84e-04	94	142	5	GO:0042440
MousePheno	increased neurotransmitter release	RBFOX3 PCLO ENTPD1	2.10e-06	4	114	3	MP:0008921
Domain	UDPGT	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-05	21	139	4	PF00201
Domain	UDPGT	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-05	21	139	4	PS00375
Domain	UDP_glucos_trans	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.59e-05	21	139	4	IPR002213
Domain	Actin-binding_Xin_repeat	XIRP1 XIRP2	5.50e-05	2	139	2	IPR012510
Domain	PACT_coil_coil	AKAP9 PCNT	5.50e-05	2	139	2	PF10495
Domain	XIRP1/XIRP2	XIRP1 XIRP2	5.50e-05	2	139	2	IPR030072
Domain	XIN	XIRP1 XIRP2	5.50e-05	2	139	2	PS51389
Domain	Xin	XIRP1 XIRP2	5.50e-05	2	139	2	PF08043
Domain	PACT_domain	AKAP9 PCNT	5.50e-05	2	139	2	IPR019528
Domain	Abi_HHR	ABI1 ABI2	1.64e-04	3	139	2	PF07815
Domain	Abl-interactor_HHR_dom	ABI1 ABI2	1.64e-04	3	139	2	IPR012849
Domain	LAM_G_DOMAIN	CNTNAP3B LAMA2 LAMA3 CELSR3	1.78e-04	38	139	4	PS50025
Domain	Laminin_G_2	CNTNAP3B LAMA2 LAMA3 CELSR3	2.18e-04	40	139	4	PF02210
Domain	Carb_anhydrase	CA10 PTPRG PTPRZ1	2.54e-04	17	139	3	PF00194
Domain	Carb_anhydrase	CA10 PTPRG PTPRZ1	2.54e-04	17	139	3	SM01057
Domain	-	CA10 PTPRG PTPRZ1	2.54e-04	17	139	3	3.10.200.10
Domain	ALPHA_CA_2	CA10 PTPRG PTPRZ1	2.54e-04	17	139	3	PS51144
Domain	Carbonic_anhydrase_a	CA10 PTPRG PTPRZ1	2.54e-04	17	139	3	IPR001148
Domain	LamG	CNTNAP3B LAMA2 LAMA3 CELSR3	3.17e-04	44	139	4	SM00282
Domain	PID_Shc-like	SHC4 SHC2	3.27e-04	4	139	2	IPR006019
Domain	EGF	CNTNAP3B TNC LAMA2 LAMA3 EGF CELSR3 BRINP2 LRP6	3.82e-04	235	139	8	SM00181
Domain	Laminin_domII	LAMA2 LAMA3	5.42e-04	5	139	2	IPR010307
Domain	Laminin_aI	LAMA2 LAMA3	5.42e-04	5	139	2	IPR009254
Domain	Laminin_I	LAMA2 LAMA3	5.42e-04	5	139	2	PF06008
Domain	Laminin_II	LAMA2 LAMA3	5.42e-04	5	139	2	PF06009
Domain	PQQ	ERN1 AASDH	8.09e-04	6	139	2	SM00564
Domain	PQQ_repeat	ERN1 AASDH	8.09e-04	6	139	2	IPR002372
Domain	PQQ_beta_propeller_repeat	ERN1 AASDH	8.09e-04	6	139	2	IPR018391
Domain	-	ERN1 AASDH	8.09e-04	6	139	2	2.140.10.10
Domain	Quinoprotein_ADH-like_fam	ERN1 AASDH	8.09e-04	6	139	2	IPR027295
Domain	Laminin_G	CNTNAP3B LAMA2 LAMA3 CELSR3	9.13e-04	58	139	4	IPR001791
Domain	PID	ANKS1B SHC4 SHC2	1.15e-03	28	139	3	PF00640
Domain	EGF_LAM_2	LAMA2 LAMA3 CELSR3	1.41e-03	30	139	3	PS50027
Domain	EGF_LAM_1	LAMA2 LAMA3 CELSR3	1.41e-03	30	139	3	PS01248
Domain	-	TMEM131 HYDIN	1.50e-03	8	139	2	2.60.40.360
Domain	Trefoil	ZP4 MGAM2	1.50e-03	8	139	2	PF00088
Domain	LAMININ_IVA	LAMA2 LAMA3	1.50e-03	8	139	2	PS51115
Domain	Laminin_B	LAMA2 LAMA3	1.50e-03	8	139	2	PF00052
Domain	LamB	LAMA2 LAMA3	1.50e-03	8	139	2	SM00281
Domain	Laminin_IV	LAMA2 LAMA3	1.50e-03	8	139	2	IPR000034
Domain	PID	ANKS1B SHC4 SHC2	1.71e-03	32	139	3	PS01179
Domain	PapD-like	TMEM131 HYDIN	1.91e-03	9	139	2	IPR008962
Domain	P_TREFOIL_2	ZP4 MGAM2	1.91e-03	9	139	2	PS51448
Domain	PD	ZP4 MGAM2	1.91e-03	9	139	2	SM00018
Domain	EGF_Lam	LAMA2 LAMA3 CELSR3	2.22e-03	35	139	3	SM00180
Domain	Laminin_EGF	LAMA2 LAMA3 CELSR3	2.22e-03	35	139	3	PF00053
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9 UROS	1.15e-05	41	103	5	M7399
Pathway	WP_ESTROGEN_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.78e-05	22	103	4	MM15888
Pathway	REACTOME_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.55e-05	24	103	4	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.02e-05	25	103	4	M17787
Pathway	WP_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.02e-05	25	103	4	MM15820
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.02e-05	25	103	4	M605
Pathway	WP_GLUCURONIDATION	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.55e-05	26	103	4	M39404
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.81e-05	28	103	4	M19580
Pathway	WP_CODEINE_AND_MORPHINE_METABOLISM	UGT1A10 UGT1A8 UGT1A9	1.30e-04	14	103	3	M39328
Pathway	REACTOME_PARACETAMOL_ADME	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.82e-04	39	103	4	MM15695
Pathway	REACTOME_ASPIRIN_ADME	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.18e-04	45	103	4	MM15694
Pubmed	Circadian Clock Component Rev-erbα Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.97e-09	6	142	4	32527940
Pubmed	A spastic paraplegia mouse model reveals REEP1-dependent ER shaping.	RBFOX3 TIMM23B TIMM23 AP1G1	3.97e-09	6	142	4	24051375
Pubmed	Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.97e-09	6	142	4	20297805
Pubmed	Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.23e-09	7	142	4	8467709
Pubmed	Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.23e-09	7	142	4	8464825
Pubmed	Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitus.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.23e-09	7	142	4	27514509
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MIA3 HSDL2 ERC1 SEC24A SIPA1L3 CACHD1 ARHGAP39 ITPR2 FANCD2 C2CD3 AKAP9 PTPRG ABI2 PTPRZ1 MIOS CSTF3 LRP6 PUM1 CPVL PCNT	1.13e-08	1049	142	20	27880917
Pubmed	Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.84e-08	8	142	4	20610558
Pubmed	Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.84e-08	8	142	4	18052087
Pubmed	Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.84e-08	8	142	4	17179145
Pubmed	A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.30e-08	9	142	4	22511988
Pubmed	Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.49e-08	10	142	4	23642732
Pubmed	UDP-glucuronosyltransferases.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.49e-08	10	142	4	11465080
Pubmed	A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.49e-08	10	142	4	23371916
Pubmed	A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.49e-08	10	142	4	22558097
Pubmed	Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region.	UGT1A10 UGT1A8 UGT1A9	6.66e-08	3	142	3	12847094
Pubmed	Cooperative Regulation of Intestinal UDP-Glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4α Is Mediated by a Novel Composite Regulatory Element.	UGT1A10 UGT1A8 UGT1A9	6.66e-08	3	142	3	29519853
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.29e-07	12	142	4	20308471
Pubmed	Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.29e-07	12	142	4	19419973
Pubmed	Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.29e-07	12	142	4	11434514
Pubmed	UGT1A1 is a major locus influencing bilirubin levels in African Americans.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.85e-07	13	142	4	22085899
Pubmed	Genome-wide analysis of hepatic lipid content in extreme obesity.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.85e-07	13	142	4	25246029
Pubmed	Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.58e-07	14	142	4	21646302
Pubmed	Human UDP-glucuronosyltransferases: metabolism, expression, and disease.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.58e-07	14	142	4	10836148
Pubmed	The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.58e-07	14	142	4	9295054
Pubmed	Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.58e-07	14	142	4	14672974
Pubmed	Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A16 and 28.	UGT1A10 UGT1A7 UGT1A9	2.66e-07	4	142	3	17558305
Pubmed	Genome-wide association meta-analysis for total serum bilirubin levels.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.67e-07	16	142	4	19414484
Pubmed	Genome-wide association of serum bilirubin levels in Korean population.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.08e-07	17	142	4	20639394
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 NDST1 ABCA2 TIMM23B SIPA1L3 DYRK1A MLLT10 SPPL2B ZZEF1 ITPR2 C2CD3 CELSR3 SCARB1 KCTD15 PUM1 SPEN CPVL PCNT	6.49e-07	1105	142	18	35748872
Pubmed	Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.	UGT1A8 UGT1A7 UGT1A9	6.62e-07	5	142	3	20565459
Pubmed	Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.	UGT1A10 UGT1A8 UGT1A9	6.62e-07	5	142	3	15057901
Pubmed	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.80e-07	18	142	4	20056724
Pubmed	A genome-wide assessment of variability in human serum metabolism.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.84e-07	19	142	4	23281178
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	MIA3 ERN1 HLA-B HSDL2 PODXL SEC24A TIMM23B TIMM23 ACTG2 SLC4A2 NUP205 ITPR2 TMTC3 SCARB1 TMEM131 CPVL	1.91e-06	952	142	16	38569033
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 CYLD CACNA1A MIA3 ABI1 ERC1 SIPA1L3 ANKS1B DYRK1A ZNF318 ARHGAP39 FBXO2 AKAP9 ABI2 MIOS PCNT	2.21e-06	963	142	16	28671696
Pubmed	Genetic determinants influencing human serum metabolome among African Americans.	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.66e-06	24	142	4	24625756
Pubmed	Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis.	RBFOX3 TNC LAMA2 PTPRZ1	3.15e-06	25	142	4	19373938
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	CNTNAP3B ABCA2 TNC LAMA3 TMTC3 SCARB1 TMEM131	5.31e-06	164	142	7	32409323
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CYLD NDST1 ABCA2 RBFOX3 HLA-B ERC1 ENPP2 SIPA1L3 ANKS1B DYRK1A CACHD1 CELSR3 OTOF KCNN1 TMEM131 USPL1 MPPED2 PCNT	5.38e-06	1285	142	18	35914814
Pubmed	Family-based genome-wide association scan of attention-deficit/hyperactivity disorder.	UGT1A10 UGT1A8 UGT1A9	5.50e-06	9	142	3	20732626
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	CACNA1A DNAH3 XIRP1 ZNF148 XIRP2 HOXD13 GLI3 TET3	5.58e-06	233	142	8	37704626
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CYLD ERC1 URB2 CSMD3 AKAP9 BRINP2 PUM1 SPEN TET3 PCNT	7.27e-06	407	142	10	12693553
Pubmed	Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.	UGT1A8 UGT1A7 UGT1A9	1.07e-05	11	142	3	18695635
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 CYLD ABI1 ARHGEF28 ERC1 SEC24A SIPA1L3 DYRK1A ANKRD27 C2CD3 AKAP9 CCSER2 PATJ PUM1	1.26e-05	861	142	14	36931259
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	TANC2 CYLD MIA3 ERC1 SIPA1L3 AKAP9 CCSER2 PATJ PUM1 CPVL	1.60e-05	446	142	10	24255178
Pubmed	DNMT3B attenuated the inhibition of TET3 on epithelial-mesenchymal transition in TGF-β1-induced ovarian cancer by methylating the TET3 promoter.	TET3 DNMT3B	1.66e-05	2	142	2	36242939
Pubmed	Emergence of Xin demarcates a key innovation in heart evolution.	XIRP1 XIRP2	1.66e-05	2	142	2	18682726
Pubmed	Aberrant production of tenascin-C in globoid cell leukodystrophy alters psychosine-induced microglial functions.	GALC TNC	1.66e-05	2	142	2	25192051
Pubmed	Polymorphisms in GNMT and DNMT3b are associated with methotrexate treatment outcome in plaque psoriasis.	GNMT DNMT3B	1.66e-05	2	142	2	33714108
Pubmed	Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.	UGT1A7 UGT1A9	1.66e-05	2	142	2	11677206
Pubmed	Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.	UGT1A10 UGT1A8	1.66e-05	2	142	2	10497143
Pubmed	Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.	UGT1A7 UGT1A9	1.66e-05	2	142	2	12944498
Pubmed	Assignment of laminin alpha 2-chain gene (Lama2) to mouse chromosome 10A4-B1 by fluorescence in situ hybridization.	ENPP2 LAMA2	1.66e-05	2	142	2	10702665
Pubmed	Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.	UGT1A7 UGT1A9	1.66e-05	2	142	2	17529886
Pubmed	Macromolecular organization of basement membranes.	LAMA2 LAMA3	1.66e-05	2	142	2	8939648
Pubmed	Role for the Abi/wave protein complex in T cell receptor-mediated proliferation and cytoskeletal remodeling.	ABI1 ABI2	1.66e-05	2	142	2	16401422
Pubmed	Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10.	UGT1A10 UGT1A9	1.66e-05	2	142	2	25547628
Pubmed	Binding of FUN14 Domain Containing 1 With Inositol 1,4,5-Trisphosphate Receptor in Mitochondria-Associated Endoplasmic Reticulum Membranes Maintains Mitochondrial Dynamics and Function in Hearts in Vivo.	FUNDC1 ITPR2	1.66e-05	2	142	2	28942427
Pubmed	PUM1 modulates trophoblast cell proliferation and migration through LRP6.	LRP6 PUM1	1.66e-05	2	142	2	34734756
Pubmed	The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia.	ABI1 ABI2	1.66e-05	2	142	2	11516653
Pubmed	Reduced level of epidermal growth factor in the skeletal muscle of mice with muscular dystrophy.	LAMA2 EGF	1.66e-05	2	142	2	1577403
Pubmed	Hormonal regulation of mitochondrial Tim23 gene expression in the mouse mammary gland.	TIMM23B TIMM23	1.66e-05	2	142	2	11165051
Pubmed	Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues.	UGT1A10 UGT1A8	1.66e-05	2	142	2	11901093
Pubmed	Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.	UGT1A10 UGT1A9	1.66e-05	2	142	2	22031623
Pubmed	Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.	UGT1A8 UGT1A9	1.66e-05	2	142	2	18568343
Pubmed	Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes.	UGT1A10 UGT1A8	1.66e-05	2	142	2	17603215
Pubmed	UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.	UGT1A7 UGT1A9	1.66e-05	2	142	2	15709193
Pubmed	Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy.	FUNDC1 NR4A1	1.66e-05	2	142	2	39247823
Pubmed	Effect of Tim23 knockdown in vivo on mitochondrial protein import and retrograde signaling to the UPRmt in muscle.	TIMM23B TIMM23	1.66e-05	2	142	2	29949403
Pubmed	Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon.	UGT1A10 UGT1A8	1.66e-05	2	142	2	9647757
Pubmed	The Xin repeat-containing protein, mXinβ, initiates the maturation of the intercalated discs during postnatal heart development.	XIRP1 XIRP2	1.66e-05	2	142	2	23261932
Pubmed	How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?	UGT1A10 UGT1A9	1.66e-05	2	142	2	20089735
Pubmed	Structure, Expression, and Function of a Novel Intercalated Disc Protein, Xin.	XIRP1 XIRP2	1.66e-05	2	142	2	16708114
Pubmed	Gene Regulatory and Expression Differences between Mouse and Pig Limb Buds Provide Insights into the Evolutionary Emergence of Artiodactyl Traits.	TBX4 HOXD13 GLI3	2.35e-05	14	142	3	32268095
Pubmed	Mouse Twist is required for fibroblast growth factor-mediated epithelial-mesenchymal signalling and cell survival during limb morphogenesis.	TBX4 HOXD13 GLI3	2.35e-05	14	142	3	12175489
Pubmed	Calcium channels link the muscle-derived synapse organizer laminin β2 to Bassoon and CAST/Erc2 to organize presynaptic active zones.	CACNA1A ERC1 PCLO	2.35e-05	14	142	3	21228161
Pubmed	Discovery and refinement of loci associated with lipid levels.	SPTLC3 ATG7 UGT1A10 UGT1A8 UGT1A7 UGT1A9 SCARB1	2.72e-05	211	142	7	24097068
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	TANC2 CYLD TIMM23B PCLO SIPA1L3 TIMM23 ARHGAP39	3.35e-05	218	142	7	33378226
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	MIA3 HSDL2 ERC1 TIMM23 CACHD1 URB2 SLC4A2 NUP205 FANCD2 TMTC3 AP1G1 CSTF3 LRP6 PUM1	3.37e-05	942	142	14	31073040
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	NDST1 ABCA2 MIA3 HLA-B PODXL RNF149 CACHD1 ZZEF1 SLC4A2 ITPR2 CELSR3 TMTC3 SCARB1 LRP6 TMEM131 CPVL	3.40e-05	1201	142	16	35696571
Pubmed	Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice.	SOX5 HOXD13 GLI3	3.59e-05	16	142	3	17222543
Pubmed	Ten-eleven translocation 1 mediated-DNA hydroxymethylation is required for myelination and remyelination in the mouse brain.	RBFOX3 ITPR2 TET3	3.59e-05	16	142	3	34429415
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PRUNE2 SPTLC3 MIA3 ATG7 SIPA1L3 LAMA3 ARHGAP39 SPPL2B SMPDL3B SHC2 PTPRG GALNT11 SCARB1 ENTPD1 CSTF3 PATJ TET3 PCNT	3.83e-05	1489	142	18	28611215
Pubmed	Musculoskeletal integration at the wrist underlies the modular development of limb tendons.	SOX5 HOXD13 GLI3	4.35e-05	17	142	3	26062940
Pubmed	Sall genes regulate region-specific morphogenesis in the mouse limb by modulating Hox activities.	TBX4 HOXD13 GLI3	4.35e-05	17	142	3	19168674
Pubmed	Formation of proximal and anterior limb skeleton requires early function of Irx3 and Irx5 and is negatively regulated by Shh signaling.	TBX4 HOXD13 GLI3	4.35e-05	17	142	3	24726282
Pubmed	Regulation of cell-cell adhesion by Abi/Diaphanous complexes.	ABI1 ABI2	4.95e-05	3	142	2	19158278
Pubmed	Identification of two new members of the CSMD gene family.	CSMD2 CSMD3	4.95e-05	3	142	2	12906867
Pubmed	Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system.	RBFOX3 DNMT3B	4.95e-05	3	142	2	15672446
Pubmed	Tim50 is a subunit of the TIM23 complex that links protein translocation across the outer and inner mitochondrial membranes.	TIMM23B TIMM23	4.95e-05	3	142	2	12437925
Pubmed	Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.	UGT1A7 UGT1A9	4.95e-05	3	142	2	16636344
Pubmed	Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.	UGT1A10 UGT1A9	4.95e-05	3	142	2	20007669
Pubmed	Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites.	UGT1A10 UGT1A8	4.95e-05	3	142	2	19244109
Pubmed	Novel RPTPγ and RPTPζ splice variants from mixed neuron-astrocyte hippocampal cultures as well as from the hippocampi of newborn and adult mice.	PTPRG PTPRZ1	4.95e-05	3	142	2	38952869
Pubmed	Association analysis and polygenic risk score evaluation of 38 GWAS-identified Loci in a Chinese population with Parkinson's disease.	DYRK1A KCNS3	4.95e-05	3	142	2	34352340
Pubmed	Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson's disease.	TIMM23B TIMM23	4.95e-05	3	142	2	30405116
Pubmed	Receptor protein tyrosine phosphatase gamma is a marker for pyramidal cells and sensory neurons in the nervous system and is not necessary for normal development.	RBFOX3 PTPRG	4.95e-05	3	142	2	16782895
Pubmed	UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients.	UGT1A8 UGT1A9	4.95e-05	3	142	2	19225446
Pubmed	Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer.	UGT1A7 UGT1A9	4.95e-05	3	142	2	17406868
Interaction	SYNE3 interactions	TANC2 CYLD MIA3 ERC1 SEC24A SIPA1L3 ZNF318 C2CD3 TMTC3 GLI3 CCSER2 TMEM131 PUM1 PCNT	3.19e-06	444	142	14	int:SYNE3
Cytoband	2q37	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.59e-06	31	142	4	2q37
GeneFamily	UDP glucuronosyltransferases	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.39e-05	32	96	4	363
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_200	TBX15 SPTLC3 TBX4 ZNF148 TNC CSRNP3 HOXD13 ENTPD1 MFSD1	1.46e-06	169	136	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	SPTLC3 TBX4 ZNF148 ENPP2 LAMA3 CACHD1 KCTD1 C2CD3 TMTC3 PTPRG CSRNP3 HOXD13 PTPRZ1 GLI3 ENTPD1 CSTF3 MPPED2	8.74e-06	769	136	17	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	TANC2 SOX5 GALC ERN1 HSDL2 PODXL MUC16 BCAT2 CACHD1 CSMD3 ITPR2 SMPDL3B AKAP9 PTPRG ABI2 PATJ	4.78e-05	791	136	16	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A DNAH3 RBFOX3 CATSPERD CSMD2 CSMD3 KCNN1 PATJ	6.70e-08	167	142	8	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	CACNA1A PRUNE2 ARHGEF28 TNC ANKS1B LAMA3 ACTG2 ENTPD1	1.35e-07	183	142	8	818fd886e0188091310825f9145fa53328f2c979
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1A PRUNE2 ARHGEF28 TNC ANKS1B LAMA3 ACTG2 ENTPD1	1.35e-07	183	142	8	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	PRUNE2 ARHGEF28 TNC ANKS1B LAMA3 ACTG2 NEDD9 ENTPD1	1.67e-07	188	142	8	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	PRUNE2 ARHGEF28 TNC ANKS1B LAMA3 ACTG2 NEDD9 ENTPD1	1.73e-07	189	142	8	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ADAMTS19 ARHGEF28 ENPP2 ITPR2 NEDD9 AKAP9 LRP6 PUM1	1.96e-07	192	142	8	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SOX5 NOL4 TBX4 TNC LAMA2 UROC1 ENTPD1 BRINP2	2.20e-07	195	142	8	f5e91ce20a7ce528dc4c1a968c7bf096bf45c528
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX5 TBX4 TNC ENPP2 LAMA2 ACTG2 ENTPD1 KCNS3	2.20e-07	195	142	8	2414b158dc7bdec43a9671544bfb7ffc5f5168fd
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS19 NDST1 PODXL ANKS1B EGF PTPRZ1 LRP6 MGAM2	2.67e-07	200	142	8	7c2d499af60654b7b28f172ac2c914ad49fb74b4
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	SOX5 CACNA1A PRUNE2 TNC LAMA3 ACTG2 ENTPD1	1.31e-06	171	142	7	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PRUNE2 CNTNAP3B TBX4 PTPRG XIRP2 ENTPD1 MPPED2	1.77e-06	179	142	7	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TANC2 PRUNE2 RNF149 ARHGAP39 HSD3B7 BST1 PATJ	2.13e-06	184	142	7	15ea746c77785120f69f9ab370fb7eb9b70692f8
ToppCell	droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TANC2 PRUNE2 RNF149 ARHGAP39 HSD3B7 BST1 PATJ	2.13e-06	184	142	7	bd5e8fc453a6393b8778734a2c3c2f1281769bcd
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SOX5 TBX4 TNC ENPP2 LAMA2 ACTG2 ENTPD1	2.29e-06	186	142	7	e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 PRUNE2 SPTLC3 PTPRG GLI3 PATJ HYDIN	2.37e-06	187	142	7	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ATG7 ENTPD1 MPPED2 CPVL MFSD1 TET3 MUC6	2.55e-06	189	142	7	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	SOX5 TNC UGT1A8 LAMA3 CACHD1 PTPRZ1 PATJ	2.64e-06	190	142	7	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	IPF-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	ABI1 TNC UGT1A8 LAMA3 CACHD1 PTPRG PTPRZ1	2.64e-06	190	142	7	4f15842b424eefadbfe451875e517cf70e29607f
ToppCell	tumor_Lung-Fibroblasts-Mesothelial_cells\|Fibroblasts / Location, Cell class and cell subclass	CNTNAP3B PODXL PCLO MUC16 FBXO2 SMPDL3B BRINP2	2.64e-06	190	142	7	d82ab67735c1f365d4b0e02b5fa91c64cdc234da
ToppCell	10x5'v1-week_12-13-Mesenchymal_fibro-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TBX15 SPTLC3 ADAMTS19 TBX4 LAMA2 GLI3 MPPED2	2.82e-06	192	142	7	4ed5040594ba2d0639f0990697504ecef872ca70
ToppCell	10x5'v1-week_12-13-Mesenchymal_fibro\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TBX15 SPTLC3 ADAMTS19 TBX4 LAMA2 GLI3 MPPED2	2.82e-06	192	142	7	d4f5d6653564c2c5d0f5f7c932d89cb1b1412844
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	SOX5 TNC UGT1A8 LAMA3 CACHD1 PTPRZ1 PATJ	2.82e-06	192	142	7	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ENPP2 LAMA2 MAMDC4 SHC2 GLI3 KCTD15 KCNS3	2.92e-06	193	142	7	64edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCell	10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SPTLC3 ADAMTS19 TBX4 RHOD LAMA2 GLI3 MPPED2	2.92e-06	193	142	7	3d85c28f6ebdcb15e875ad01d52d6c138fbf8525
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ADAMTS19 ARHGEF28 DYRK1A ITPR2 NEDD9 AKAP9 PUM1	2.92e-06	193	142	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 ARHGEF28 LAMA3 KCTD1 PATJ CPVL HYDIN	3.02e-06	194	142	7	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF28 PCLO KCTD1 EGF PATJ MPPED2 HYDIN	3.02e-06	194	142	7	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	BL-critical-LOC-Epithelial-Basal\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TNC UGT1A8 LAMA3 PTPRG CSRNP3 PTPRZ1 KCNS3	3.02e-06	194	142	7	2932f704656ca368565ec12f3452af3b18e8df12
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX5 TBX4 TNC ENPP2 LAMA2 ENTPD1 KCNS3	3.13e-06	195	142	7	b0d408f8bc1701a87596ed55efcd90749fee33e6
ToppCell	LA-08._Macrophage\|LA / Chamber and Cluster_Paper	ATG7 RNF149 ENTPD1 MPPED2 CPVL TET3 MUC6	3.13e-06	195	142	7	5e1d5bdb8874091f5a2b1d0a8cc9008165718a97
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX5 TBX4 TNC ENPP2 LAMA2 ENTPD1 KCNS3	3.13e-06	195	142	7	a486a7acea0e91048cc48afa0dbd3926d30bc217
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 SOX5 ERC1 SIPA1L3 ANKS1B DYRK1A PTPRG	3.24e-06	196	142	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF28 PCLO SIPA1L3 KCTD1 EGF PATJ MPPED2	3.24e-06	196	142	7	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	mLN-B_cell-B_cell_IgA_Plasma\|B_cell / Region, Cell class and subclass	TBX15 ERN1 TNC CA10 SMPDL3B CPVL SEC14L2	3.58e-06	199	142	7	09494953bc7fff63cf2763ea89fca7abb97c186f
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A CSMD2 CSMD3 CA10 CSRNP3 PTPRZ1 MPPED2	3.70e-06	200	142	7	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A CSMD2 CSMD3 CA10 CSRNP3 PTPRZ1 MPPED2	3.70e-06	200	142	7	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A CSMD2 CSMD3 CA10 CSRNP3 PTPRZ1 MPPED2	3.70e-06	200	142	7	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A CSMD2 CSMD3 CA10 CSRNP3 PTPRZ1 MPPED2	3.70e-06	200	142	7	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A CSMD2 CSMD3 CA10 CSRNP3 PTPRZ1 MPPED2	3.70e-06	200	142	7	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Biopsy_Other_PF-Epithelial-Basal\|Biopsy_Other_PF / Sample group, Lineage and Cell type	RHOD TNC UGT1A7 LAMA3 KCTD1 FBXO2 PTPRZ1	3.70e-06	200	142	7	7098ae4b0ea8ba607519eaed8577c577530fc2a1
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A CSMD2 CSMD3 CA10 CSRNP3 PTPRZ1 MPPED2	3.70e-06	200	142	7	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SOX5 PRUNE2 ADCK5 LAMA2 ACTG2 PTPRG	1.06e-05	155	142	6	cd7d95cbcad248670e531d80bb83c55e36ebc573
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX5 CACNA1A CSMD2 CA10 SPTBN5 PTPRZ1	1.06e-05	155	142	6	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A DNAH3 RBFOX3 CSMD2 CSMD3 XIRP2	1.22e-05	159	142	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS19 LAMA2 PTPRG PTPRZ1 CPVL HYDIN	1.26e-05	160	142	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS19 LAMA2 PTPRG PTPRZ1 CPVL HYDIN	1.26e-05	160	142	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	PRUNE2 RBFOX3 ACTG2 NR4A1 CSRNP3 MPPED2	1.61e-05	167	142	6	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	Control\|World / group, cell type (main and fine annotations)	SOX5 ARHGEF28 ANKS1B LAMA3 NEDD9 PATJ	1.67e-05	168	142	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNC UGT1A7 LAMA3 TMTC3 PTPRZ1 GLI3	1.78e-05	170	142	6	0cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF149 NR4A1 HSD3B7 SMPDL3B OTOF SCARB1	1.78e-05	170	142	6	7cb7ad9ab064b6ea452545d145e5b1d4090cd4c1
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNC UGT1A7 LAMA3 TMTC3 PTPRZ1 GLI3	1.78e-05	170	142	6	2d880223d01bde4bf777bd6f50b7d2768489075f
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF149 NR4A1 HSD3B7 SMPDL3B OTOF SCARB1	1.78e-05	170	142	6	db7cee7e518debb2cbe9eeae05d47e14b69cb8e3
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PCLO MUC16 FBXO2 SMPDL3B BRINP2 NPAS1	1.97e-05	173	142	6	3d7c281a1a9f183a5a861d1a9c7b50d216535893
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PCLO MUC16 FBXO2 SMPDL3B BRINP2 NPAS1	1.97e-05	173	142	6	3aa90578371039f81b7c6fa873ec70f8f2bc7dfa
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX5 ARHGEF28 TRPC5 CACHD1 CA10 CPVL	2.03e-05	174	142	6	bc978a2148a0261a4f9d1ca5479b707e224566be
ToppCell	5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A NOL4 XIRP1 SHC2 KCNS3 POTEJ	2.10e-05	175	142	6	182e45f5c02214d6b9f317ff5dc43af8b42de978
ToppCell	368C-Epithelial_cells-Epithelial-B_(AT2)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	PCLO LAMA3 GNMT MAMDC4 SMPDL3B EGF	2.24e-05	177	142	6	ac8f774596068e66c0a9ea8a318be0ce5f5df834
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX5 ARHGEF28 TRPC5 CACHD1 CA10 CPVL	2.24e-05	177	142	6	f30d757ee8db7e10d547498dab6560473c6ed7c0
ToppCell	368C-Epithelial_cells-Epithelial-B_(AT2)\|368C / Donor, Lineage, Cell class and subclass (all cells)	PCLO LAMA3 GNMT MAMDC4 SMPDL3B EGF	2.24e-05	177	142	6	d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 CACNA1A PRUNE2 PCLO SHC2 CELSR3	2.31e-05	178	142	6	30ca37f70d267cc9b40ca3e211f16d30360c3e6b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A NOL4 DNAH3 CATSPERD ANKS1B PATJ	2.54e-05	181	142	6	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 ADAMTS19 TBX4 LAMA2 LRP6 KCNS3	2.78e-05	184	142	6	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA2 LAMA3 KCTD1 CSMD2 CA10 ITPR2	2.78e-05	184	142	6	6475a43201b136dcc9b113d2ca4cfa154ed9d65d
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 TBX4 TNC ANKS1B LAMA2 ACTG2	2.87e-05	185	142	6	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX5 PRUNE2 TBX4 TNC ANKS1B ACTG2	2.87e-05	185	142	6	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 PRUNE2 ARHGAP39 HSD3B7 BST1 PATJ	2.96e-05	186	142	6	f1aa0c58336d23bcbe52a59e7af954d20085bdb6
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PCLO LAMA3 MUC16 CSMD3 TET3 PIWIL3	2.96e-05	186	142	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	droplet-Lung-nan-21m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 PRUNE2 ARHGAP39 HSD3B7 BST1 PATJ	2.96e-05	186	142	6	8f77e552e613b6e124443c7f6ef5c1316a5ff8db
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX5 ANKS1B SHC4 KCTD1 NR4A1 PTPRZ1	2.96e-05	186	142	6	76535681667c8afb884fa72b6edfee9e1e46335b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 SPTLC3 PTPRG GLI3 PATJ HYDIN	2.96e-05	186	142	6	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	SOX5 PRUNE2 TNC LAMA2 ACTG2 PTPRG	3.05e-05	187	142	6	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	CNTNAP3B ARHGEF28 PODXL ENPP2 PTPRG ENTPD1	3.05e-05	187	142	6	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 PRUNE2 SPTLC3 PTPRG PATJ HYDIN	3.14e-05	188	142	6	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 CNTNAP3B PODXL ENPP2 LAMA3 ENTPD1	3.23e-05	189	142	6	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ADAMTS19 ADCK5 ENPP2 ACTG2 FBXO2	3.23e-05	189	142	6	4dc32b463546bbe7250dddd281b92ad17ec22da1
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ADAMTS19 ADCK5 ENPP2 ACTG2 FBXO2	3.23e-05	189	142	6	0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SPTLC3 KCTD1 CA10 NEDD9 PTPRG	3.33e-05	190	142	6	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATG7 ENPP2 ITPR2 ENTPD1 MPPED2 MFSD1	3.33e-05	190	142	6	f573fef3762a30c38cf8fa7f45df0ffbb49dc873
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SPTLC3 KCTD1 CA10 NEDD9 PTPRG	3.33e-05	190	142	6	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SPTLC3 KCTD1 CA10 NEDD9 PTPRG	3.43e-05	191	142	6	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	COPD-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	SOX5 ENPP2 NR4A1 ITPR2 PTPRG ENTPD1	3.43e-05	191	142	6	ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 NOL4 ENPP2 PCLO SLC7A14 TMTC3	3.43e-05	191	142	6	f76f3f5c7902a3659d8cbe470f96ce57c8a6744d
ToppCell	COVID-19-kidney-TAL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTLC3 ARHGEF28 KCTD1 CA10 EGF PATJ	3.43e-05	191	142	6	fe55475ce0666ab5122447a813dc2369e24947b8
ToppCell	COVID-19-kidney-Mito-rich_Distal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTLC3 ARHGEF28 KCTD1 CA10 EGF PATJ	3.43e-05	191	142	6	0965f621ebcd92ccdeb21cc27022180ce3cfe910
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B PODXL ENPP2 LAMA3 PTPRG ENTPD1	3.53e-05	192	142	6	3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 CNTNAP3B PODXL ENPP2 LAMA3 ENTPD1	3.53e-05	192	142	6	56b021c297a21dff357531f21e2464f85186106d
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 TNC CACHD1 KCTD1 PTPRZ1 HYDIN	3.64e-05	193	142	6	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	Immune-interstitial_macrophage_(C1Q_positive)\|World / Lineage, Cell type, age group and donor	ENPP2 ITPR2 ENTPD1 MPPED2 CPVL MFSD1	3.64e-05	193	142	6	64d598162a256ac6c9f8280c8a9133661dfbb10f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ARHGEF28 PCLO SIPA1L3 KCTD1 PATJ	3.64e-05	193	142	6	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SOX5 TBX4 ENPP2 ANKS1B PTPRG GLI3	3.74e-05	194	142	6	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	ATG7 RNF149 ENTPD1 MPPED2 TET3 MUC6	3.74e-05	194	142	6	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATG7 RNF149 ITPR2 ENTPD1 MFSD1 TET3	3.74e-05	194	142	6	663e7e7fe48157e808b4f1a0ea6ad41944e857a2
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NOL4 MUC16 CELSR3 OTOF POTEJ HYDIN	3.74e-05	194	142	6	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	RA-08._Macrophage\|RA / Chamber and Cluster_Paper	RNF149 ENTPD1 MPPED2 CPVL TET3 MUC6	3.74e-05	194	142	6	ac26e5c71d5069622de72fa25a9c920887ac2c19
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 CNTNAP3B PODXL ENPP2 LAMA3 ENTPD1	3.85e-05	195	142	6	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	ATG7 RNF149 ITPR2 MPPED2 CPVL MFSD1	3.85e-05	195	142	6	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TBX4 TNC ENPP2 LAMA2 ACTG2 ENTPD1	3.85e-05	195	142	6	2eed0332e338d6f0dbcb399d9d36c4611d491b0a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SOX5 TBX4 ENPP2 ANKS1B PTPRG GLI3	3.85e-05	195	142	6	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	facs-Aorta-Heart-3m-Endothelial\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBFOX3 PODXL LAMA3 PTPRG SCARB1 ENTPD1	3.85e-05	195	142	6	8493f2f60fc356af28b9c0e287d4cd8c8899c081
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF28 PCLO SIPA1L3 KCTD1 EGF PATJ	3.85e-05	195	142	6	6477e6e7be5bd8eb99119a12ae16334ccddecd43
Computational	Developmental processes.	CDX2 TBX4 LAMA2 LAMA3 ACTG2 EGF PTPRG HOXD13 BST1 GLI3 NPAS1	4.19e-05	333	82	11	MODULE_220
Drug	naringenin chalcone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.01e-09	5	141	4	ctd:C027329
Drug	anthrarobin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.01e-09	5	141	4	ctd:C032186
Drug	1,2,5,8-tetrahydroxy anthraquinone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.09e-08	6	141	4	ctd:C543211
Drug	alloin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.09e-08	6	141	4	ctd:C006457
Drug	2',5'-dihydroxychalcone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.09e-08	6	141	4	ctd:C107497
Drug	2,2',3,5,5'-pentachlorobiphenyl	UGT1A10 UGT1A8 UGT1A7 UGT1A9 HOXD13	2.42e-08	15	141	5	CID000040469
Drug	2',4'-dihydroxychalcone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.86e-08	7	141	4	ctd:C059354
Drug	1,4-dihydroxyanthraquinone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.68e-08	8	141	4	ctd:C034890
Drug	AC1MRQNQ	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.73e-07	9	141	4	CID003522271
Drug	DHPASiU	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.73e-07	9	141	4	CID000197602
Drug	3-iodophenol	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.73e-07	9	141	4	CID000012272
Drug	AC1L4J7U	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.73e-07	9	141	4	CID000186631
Drug	Chebi:32663	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.73e-07	9	141	4	CID005460873
Drug	Woodward's reagent K	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC4A2 BST1	2.56e-07	43	141	6	CID000077804
Drug	androsterone glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9 EGF AP1G1	2.56e-07	43	141	6	CID000114833
Drug	2,6-dihydroxyanthraquinone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.88e-07	10	141	4	ctd:C034889
Drug	Hymecromone	TNC UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.08e-07	25	141	5	ctd:D006923
Drug	4-nitrophenyl)imidazole	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.50e-07	11	141	4	CID000123155
Drug	AC1O5XMV	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.50e-07	11	141	4	CID006442661
Drug	diflunisal	UGT1A10 UGT1A8 UGT1A7 UGT1A9 NT5C1A	6.14e-07	27	141	5	CID000003059
Drug	N-OH-DABZ	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.71e-07	12	141	4	CID000051366
Drug	1-O-beta-D-glucopyranosyl-D-mannitol	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.71e-07	12	141	4	CID000088735
Drug	4-hydroxyestrone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.71e-07	12	141	4	ctd:C026418
Drug	2,4,6-TCB	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.71e-07	12	141	4	CID000037247
Drug	nonanoyl-N-methylglucamide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.71e-07	12	141	4	CID000160090
Drug	7,7,7-triphenylheptanoic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.71e-07	12	141	4	CID000276709
Drug	hydratropic acid	UGT1A10 UGT1A8 UGT1A7	9.26e-07	4	141	3	ctd:C013025
Drug	2-vanillin	UGT1A10 UGT1A8 UGT1A7	9.26e-07	4	141	3	ctd:C060843
Drug	diphenylacetic acid	UGT1A10 UGT1A8 UGT1A7	9.26e-07	4	141	3	ctd:C037760
Drug	2-hydroxyestrone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.65e-07	13	141	4	ctd:C024980
Drug	tritanol	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.65e-07	13	141	4	CID000006457
Drug	5-azido-UDP-glucuronic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.65e-07	13	141	4	CID003081279
Drug	cotinine-N-glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.65e-07	13	141	4	CID000000411
Drug	alizarin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.65e-07	13	141	4	ctd:C010078
Drug	propranolol glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.34e-06	14	141	4	CID000119515
Drug	PCB-61	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.34e-06	14	141	4	CID000036401
Drug	norbuprenorphine	UGT1A10 UGT1A8 UGT1A7 ACO2 UGT1A9	1.75e-06	33	141	5	CID000114976
Drug	6-methylsalicylic acid	UGT1A10 ENPP2 UGT1A8 UGT1A7 UGT1A9	1.75e-06	33	141	5	CID000011279
Drug	afloqualone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.82e-06	15	141	4	CID000002040
Drug	naphthyl sulphate	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.82e-06	15	141	4	CID000114775
Drug	coumarin-3-carboxylic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.82e-06	15	141	4	CID000010752
Drug	bergamottin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.82e-06	15	141	4	ctd:C068337
Drug	sulforaphane nitrile	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.82e-06	15	141	4	CID000543743
Drug	estragole	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SPEN	2.04e-06	34	141	5	CID000008815
Drug	isovaleric acid	UGT1A10 UGT1A8 UGT1A7	2.30e-06	5	141	3	ctd:C008216
Drug	biphenylylacetic acid	UGT1A10 UGT1A8 UGT1A7	2.30e-06	5	141	3	ctd:C012776
Drug	quercetin-3,4'-diglucoside	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.42e-06	16	141	4	CID005320835
Drug	1'-hydroxyestragole	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.42e-06	16	141	4	CID000040003
Drug	bilirubin-phosphate	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.42e-06	16	141	4	CID005497144
Drug	muraglitazar	UGT1A10 UGT1A8 UGT1A7 UGT1A9 EGF	2.74e-06	36	141	5	CID000206044
Drug	anisole	UGT1A10 UGT1A8 UGT1A7 UGT1A9 HOXD13	2.74e-06	36	141	5	CID000007519
Drug	3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.15e-06	17	141	4	CID000003573
Drug	6-hydroxychrysene	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.15e-06	17	141	4	CID000037766
Drug	acotiamide	UGT1A10 UGT1A8 UGT1A7 UGT1A9 CPVL	3.15e-06	37	141	5	CID005282338
Drug	SureCN12722713	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.03e-06	18	141	4	CID005488034
Drug	ethyl-beta-D-6-glucosiduronic acid	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.03e-06	18	141	4	CID000152226
Drug	Br 2	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.03e-06	18	141	4	CID003060900
Drug	2,3,7-trichlorodibenzo-p-dioxin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.03e-06	18	141	4	CID000036614
Drug	ApApG	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.03e-06	18	141	4	CID003081975
Drug	C1 11-32	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.03e-06	18	141	4	CID000443077
Drug	C11131	UGT1A10 UGT1A8 UGT1A7 UGT1A9	4.03e-06	18	141	4	CID000443076
Drug	3-phenylpropionic acid	UGT1A10 UGT1A8 UGT1A7	4.59e-06	6	141	3	ctd:C035253
Drug	Indoprofen	UGT1A10 UGT1A8 UGT1A7	4.59e-06	6	141	3	ctd:D007216
Drug	thymoquinone	UGT1A10 UGT1A8 UGT1A7 ACO2 UGT1A9	4.69e-06	40	141	5	CID000010281
Drug	9-OH-risperidone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.08e-06	19	141	4	CID000475100
Drug	5alpha-spirostan-3beta-ol	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.08e-06	19	141	4	CID000091433
Drug	almokalant	UGT1A10 UGT1A8 UGT1A7 UGT1A9	5.08e-06	19	141	4	CID003033962
Drug	AC1Q6O8B	UGT1A10 UGT1A8 UGT1A7 UGT1A9 HSD3B7	5.31e-06	41	141	5	CID000000334
Drug	5-hydroxytryptophol	UGT1A10 UGT1A8 UGT1A7 UGT1A9 AASDH	6.00e-06	42	141	5	CID000009061
Drug	eugenol	UGT1A10 UGT1A8 UGT1A7 UGT1A9 TMTC3 HOXD13	6.14e-06	73	141	6	CID000003314
Drug	tectochrysin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.32e-06	20	141	4	CID005281954
Drug	AC1L1OBF	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.32e-06	20	141	4	CID000032736
Drug	4'-hydroxydiclofenac	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.32e-06	20	141	4	CID000116545
Drug	entacapone	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.32e-06	20	141	4	ctd:C071192
Drug	7,8-benzoquinoline	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC4A2	6.76e-06	43	141	5	CID000009191
Drug	estriol-16-glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.77e-06	21	141	4	CID000122281
Drug	dulcin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.77e-06	21	141	4	CID000009013
Drug	Benzamidoxime hydrochloride	UGT1A10 UGT1A8 UGT1A7 UGT1A9	7.77e-06	21	141	4	CID000069186
Drug	amonafide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.45e-06	22	141	4	CID000050515
Drug	N-methylpiperazine	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.45e-06	22	141	4	CID000053167
Drug	plumbagin	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.45e-06	22	141	4	ctd:C014758
Drug	amidoxime	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.14e-05	23	141	4	CID000465967
Drug	estradiol-3-glucuronide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.14e-05	23	141	4	CID000066651
Drug	phenanthridine	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.14e-05	23	141	4	CID000009189
Drug	isoamyl alcohol	UGT1A10 UGT1A8 UGT1A7 UGT1A9 BCAT2	1.17e-05	48	141	5	CID000031260
Drug	retigabine	UGT1A10 UGT1A8 UGT1A7 UGT1A9 HOXD13	1.17e-05	48	141	5	CID000121892
Drug	glabridin	UGT1A10 UGT1A8 UGT1A9	1.27e-05	8	141	3	ctd:C107601
Drug	AC1L1G0K	UGT1A10 UGT1A8 UGT1A7 UGT1A9 EGF	1.30e-05	49	141	5	CID000003473
Drug	EM-652	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SCARB1	1.30e-05	49	141	5	CID000155435
Drug	campestrol	UGT1A10 UGT1A8 UGT1A7 UGT1A9 SCARB1	1.30e-05	49	141	5	CID000010134
Drug	niflumic acid	GALC ABI1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 CELSR3	1.31e-05	125	141	7	CID000004488
Drug	AS-3201	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.36e-05	24	141	4	CID000153948
Drug	phenanthroline	HLA-B UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.44e-05	50	141	5	CID000067473
Drug	p,p'-hydroxy-DDT	UGT1A10 UGT1A8 UGT1A7 UGT1A9 EGF	1.44e-05	50	141	5	CID000076302
Drug	(+/-)-Abacavir	HLA-B UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.58e-05	51	141	5	CID000001971
Drug	5-MOP	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-05	25	141	4	CID000002355
Drug	AzMC	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-05	25	141	4	CID000064986
Drug	N-acetylbenzidine	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-05	25	141	4	CID000018787
Drug	5,6-benzoquinoline	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-05	25	141	4	CID000006796
Drug	N-phenylmaleimide	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.61e-05	25	141	4	CID000013662
Disease	N-acetyl-4-chlorophenylalanine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.42e-09	5	140	4	EFO_0801060
Disease	5-hydroxyindole sulfate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.42e-09	5	140	4	EFO_0800085
Disease	nuclear receptor subfamily 1 group D member 2 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.42e-09	5	140	4	EFO_0801853
Disease	X-21339 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.68e-08	7	140	4	EFO_0800808
Disease	X-11793--oxidized bilirubin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0021260
Disease	Succinimide measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0022118
Disease	X-11530 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0021249
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0801034
Disease	cholelithiasis, bilirubin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0004570, EFO_0004799
Disease	X-11522 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0800696
Disease	X-10458 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0800692
Disease	X-24849 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0800909
Disease	serum N-desmethylclozapine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0600043
Disease	plasma clozapine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0600038
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0802740
Disease	X-16946 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.35e-08	8	140	4	EFO_0800766
Disease	X-11442 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.00e-08	9	140	4	EFO_0021236
Disease	X-11441 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.00e-08	9	140	4	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.00e-08	9	140	4	EFO_0004739
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.00e-08	9	140	4	EFO_0801037
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.00e-08	9	140	4	EFO_0801036
Disease	X-11880 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.00e-08	9	140	4	EFO_0800698
Disease	protein-tyrosine kinase 6 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.00e-08	9	140	4	EFO_0020691
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.00e-08	9	140	4	EFO_0802127
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.00e-08	9	140	4	EFO_0004570, GO_0009410
Disease	bilirubin measurement, response to tenofovir	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.97e-08	10	140	4	EFO_0004570, EFO_0009279
Disease	X-21448 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.97e-08	10	140	4	EFO_0800816
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.97e-08	10	140	4	EFO_0802185
Disease	X-23974 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.97e-08	10	140	4	EFO_0800867
Disease	indole-3-carboxylate measurement	UGT1A10 UGT1A8 UGT1A9	1.05e-07	3	140	3	EFO_0800043
Disease	blood 4-oxo-retinoic acid measurement	UGT1A10 UGT1A8 UGT1A9	1.05e-07	3	140	3	EFO_0022216
Disease	pregnenetriol sulfate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.56e-07	11	140	4	EFO_0800586
Disease	plasma N-desmethylclozapine measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.56e-07	11	140	4	EFO_0600039
Disease	histidine betaine (hercynine) measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.56e-07	11	140	4	EFO_0800972
Disease	X-21796 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.56e-07	11	140	4	EFO_0800825
Disease	insomnia, bilirubin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.56e-07	11	140	4	EFO_0004570, EFO_0004698
Disease	aldosterone measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.56e-07	11	140	4	EFO_0010219
Disease	p-cresol glucuronide measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.33e-07	12	140	4	EFO_0800079
Disease	biliverdin measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.33e-07	12	140	4	EFO_0021033
Disease	pregnenetriol disulfate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.36e-07	13	140	4	EFO_0800587
Disease	retinol dehydrogenase 16 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	3.36e-07	13	140	4	EFO_0802007
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.10e-06	17	140	4	EFO_0004611, EFO_0007800
Disease	X-21441 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.10e-06	17	140	4	EFO_0800814
Disease	angiopoietin-related protein 1 measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.41e-06	18	140	4	EFO_0801382
Disease	3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement	UGT1A10 UGT1A8 UGT1A9	2.07e-06	6	140	3	EFO_0800566
Disease	tissue factor measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.73e-06	21	140	4	EFO_0010623
Disease	neuroblastoma, cutaneous melanoma	UGT1A10 UGT1A8 UGT1A7 UGT1A9	9.10e-06	28	140	4	EFO_0000389, EFO_0000621
Disease	xanthurenate measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.05e-05	29	140	4	EFO_0010551
Disease	response to dolutegravir	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.21e-05	30	140	4	EFO_0600017
Disease	indoleacetate measurement	UGT1A10 UGT1A8 UGT1A9	1.22e-05	10	140	3	EFO_0021015
Disease	vitamin D deficiency	UGT1A10 UGT1A8 UGT1A7 UGT1A9	2.84e-05	37	140	4	EFO_0003762
Disease	X-24588 measurement	UGT1A10 UGT1A8 UGT1A9	2.89e-05	13	140	3	EFO_0800898
Disease	urate measurement, bone density	SPTLC3 PODXL ERC1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 CA10 ITPR2 NEDD9 PTPRG KCNS3	4.16e-05	619	140	12	EFO_0003923, EFO_0004531
Disease	thyroxine measurement	UGT1A10 UGT1A8 UGT1A7 LAMA3 UGT1A9	4.83e-05	83	140	5	EFO_0005130
Disease	vital capacity	TBX15 ADAMTS19 NDST1 TBX4 PODXL ERC1 ENPP2 PCLO LAMA2 MLLT10 ZZEF1 GLI3 SCARB1 LRP6 KCNS3 PATJ MPPED2	8.16e-05	1236	140	17	EFO_0004312
Disease	vitamin D measurement, COVID-19	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.71e-05	49	140	4	EFO_0004631, MONDO_0100096
Disease	gallstones	UGT1A10 UGT1A8 UGT1A7 UGT1A9 MLLT10	1.69e-04	108	140	5	EFO_0004210
Disease	urate measurement, spine bone mineral density	UGT1A10 UGT1A8 UGT1A7 UGT1A9	1.69e-04	58	140	4	EFO_0004531, EFO_0007701
Disease	Ataxia	CACNA1A UROC1 PUM1	2.23e-04	25	140	3	C0004134
Disease	bilirubin measurement	SOX5 UGT1A10 UGT1A8 UGT1A7 SIPA1L3 UGT1A9 CACHD1 EGF SCARB1	2.72e-04	442	140	9	EFO_0004570
Disease	alcohol consumption measurement	SOX5 CACNA1A HLA-B ACO2 PCLO ANKS1B CSMD3 SPTBN5 AKAP9 AP1G1 ABI2 GLI3 CSTF3 MPPED2 TET3 DNMT3B	2.80e-04	1242	140	16	EFO_0007878
Disease	attention deficit hyperactivity disorder	SOX5 ERC1 UGT1A10 UGT1A8 UGT1A9 CSMD2 CSRNP3 DNMT3B	3.00e-04	354	140	8	EFO_0003888
Disease	hypospadias (biomarker_via_orthology)	HOXD13 GLI3	3.31e-04	6	140	2	DOID:10892 (biomarker_via_orthology)
Disease	metabolite measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9 CA10 ITPR2 BST1 SCARB1 DHTKD1 SEC14L2	3.55e-04	560	140	10	EFO_0004725
Disease	facial morphology measurement	TBX15 RBFOX3 HLA-B SIPA1L3 FUNDC1 GLI3 KCTD15 KCNS3 DNMT3B	4.00e-04	466	140	9	EFO_0007841
Disease	cleft lip	TANC2 ARHGEF28 MUC16 ZNF318 ENTPD1 KCNS3 MGAM2	4.29e-04	284	140	7	EFO_0003959
Disease	Polysyndactyly	HOXD13 GLI3	4.62e-04	7	140	2	C0265553
Disease	Lymphopenia	ATG7 HOXD13	4.62e-04	7	140	2	C0024312
Disease	hormone measurement	UGT1A10 UGT1A8 UGT1A7 UGT1A9	6.98e-04	84	140	4	EFO_0004730
Disease	waist-hip ratio	TBX15 PRUNE2 NDST1 TBX4 ATG7 ZNF318 MLLT10 ZZEF1 NUP205 NEDD9 PTPRG ZSCAN30 GLI3 PATJ MPPED2	7.43e-04	1226	140	15	EFO_0004343
Disease	Abnormality of the face	PUM1 TET3	7.87e-04	9	140	2	C4025871
Disease	cholelithiasis	UGT1A10 UGT1A8 UGT1A7 UGT1A9	8.31e-04	88	140	4	EFO_0004799
Disease	lung cancer (is_marker_for)	TNC CCL22 DNMT3B	8.43e-04	39	140	3	DOID:1324 (is_marker_for)
Disease	pleural tuberculosis (is_marker_for)	TNC CCL22	9.81e-04	10	140	2	DOID:106 (is_marker_for)
Disease	Proteinuria	HLA-B MUC16 NR4A1	1.12e-03	43	140	3	C0033687
Disease	apolipoprotein B measurement	HLA-B UGT1A10 UGT1A8 UGT1A7 UGT1A9 BCAT2 AP1G1 SCARB1 MPPED2 HYDIN	1.29e-03	663	140	10	EFO_0004615
Disease	dodecanedioate measurement	UGT1A10 UGT1A8	1.43e-03	12	140	2	EFO_0021054
Disease	Gastrointestinal Stromal Sarcoma	NDST1 C2CD3 GLI3	1.45e-03	47	140	3	C3179349
Disease	skin melanoma (is_marker_for)	FANCD2 DNMT3B	1.68e-03	13	140	2	DOID:8923 (is_marker_for)
Disease	non-melanoma skin carcinoma	HLA-B ATG7 TRPC5 CSMD2 CPVL DNMT3B	1.71e-03	265	140	6	EFO_0009260
Disease	Gastrointestinal Stromal Tumors	NDST1 C2CD3 GLI3	1.74e-03	50	140	3	C0238198
Disease	unipolar depression	SOX5 NOL4 ERN1 HLA-B ATG7 CATSPERD TNC PCLO SHC4 CSMD3 ANKRD27 ITPR2 PTPRG KCTD15	1.83e-03	1206	140	14	EFO_0003761
Disease	Malignant neoplasm of breast	ADAMTS19 XIRP1 ACO2 RNF149 LAMA2 UGT1A9 ZNF318 MAMDC4 AKAP9 EGF OTOF SPEN DNMT3B	1.85e-03	1074	140	13	C0006142
Disease	cortical surface area measurement	TANC2 SOX5 CACNA1A ADAMTS19 ABI1 HLA-B PODXL ENPP2 LAMA2 CACHD1 ARHGAP39 GLI3 KCNS3 MPPED2 CPVL	1.86e-03	1345	140	15	EFO_0010736
Disease	free androgen index	SOX5 UGT1A10 UGT1A8 UGT1A7 UGT1A9 ZNF318 PTPRG	2.11e-03	374	140	7	EFO_0007005
Disease	leukocyte immunoglobulin-like receptor subfamily B member 1 measurement	HLA-B KIR3DX1	2.25e-03	15	140	2	EFO_0008208
Disease	Hepatitis	ENPP2 GNMT	2.25e-03	15	140	2	C0019158
Disease	body fat percentage	HLA-B ACO2 ANKS1B MLLT10 ZZEF1 PTPRG KCNS3 PATJ	2.36e-03	488	140	8	EFO_0007800
Disease	Tremor, Rubral	CACNA1A UROC1	2.57e-03	16	140	2	C0750940
Disease	Ataxia, Appendicular	CACNA1A UROC1	2.57e-03	16	140	2	C0750937
Disease	Ataxia, Motor	CACNA1A UROC1	2.57e-03	16	140	2	C0278161
Disease	Ataxia, Sensory	CACNA1A UROC1	2.57e-03	16	140	2	C0240991
Disease	Dermatitis	HLA-B EGF	2.57e-03	16	140	2	C0011603
Disease	Abnormal coordination	CACNA1A UROC1	2.57e-03	16	140	2	C0520966
Disease	Ataxia, Truncal	CACNA1A UROC1	2.57e-03	16	140	2	C0427190
Disease	digit length ratio	HOXD13 GLI3	2.57e-03	16	140	2	EFO_0004841
Disease	Moyamoya Disease	HLA-B PCNT	2.90e-03	17	140	2	C0026654
Disease	Liver carcinoma	CYLD ATG7 ACO2 UROC1 GNMT FANCD2 EGF CELSR3	2.98e-03	507	140	8	C2239176
Disease	chronotype measurement	TANC2 SOX5 NOL4 HSDL2 PODXL ACO2 ZNF318 CA10 PTPRG PATJ MPPED2	3.30e-03	882	140	11	EFO_0008328
Disease	cholangiocarcinoma (is_marker_for)	MUC16 UGT1A9 MUC6	3.53e-03	64	140	3	DOID:4947 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PTIVHDEYGAVSAGM	PTPRG	1346	P23470
QYHSMSGPLIGVALE	URB2	626	Q14146
EYHGPGVDSISCTGM	ACO2	266	Q99798
ETAQGHYMVVDTSPD	MAMDC4	851	Q6UXC1
SDSEHYLPMEGQGRA	CACNA1A	2076	O00555
VIHVMLNGSEPTGAY	BST1	186	Q10588
GPSSANMDYHEIGRS	SLC4A2	561	P04920
HNEGMQVLSLTESPY	AKAP9	2951	Q99996
ATEAGPYGANMEDSV	CCL22	21	O00626
VSMYPSSVRHSGGLN	CDX2	11	Q99626
YELHVQVTEMSPAGS	CDHR1	316	Q96JP9
MQVGVPEVTSAHFAG	CATSPERD	91	Q86XM0
PHSQMSGDSYTVGAV	CSMD2	2781	Q7Z408
NVVGMDLPSHGYTLI	CSMD3	3421	Q7Z407
ESIMNSTEYPHGGSQ	NEDD9	571	Q14511
FPVHYTDVSNMGRGA	DNMT3B	811	Q9UBC3
GAQEMGTVAAHVPYG	NT5C1A	336	Q9BXI3
YTSSMEVVGPNTKGH	HSD3B7	126	Q9H2F3
TESDHGYSTMSPQED	CACHD1	1191	Q5VU97
VTGLFPGNYVESIMH	ABI1	491	Q8IZP0
SFIGMESAGIHETTY	ACTG2	266	P63267
GVEENSPGYLEVMSA	ADCK5	111	Q3MIX3
TMDPTTGLIYIGSHD	AASDH	861	Q4L235
QFSANTGPAHYMTEG	DYRK1A	721	Q13627
GVDGDTVNMFVVHPT	DHTKD1	726	Q96HY7
VTGLFPGNYVESIMH	ABI2	496	Q9NYB9
PMYLSDHENVGSETP	ERC1	71	Q8IUD2
SVSAYQHGMTFPGTD	QRICH2	301	Q9H0J4
DSTGFISVRPYQHGM	QRICH2	831	Q9H0J4
GDYSTMEGPELRHSQ	ARHGAP39	446	Q9C0H5
QDYSGQTPVPTEHGM	RBFOX3	31	A6NFN3
VVADPAMVSYHGADA	ADAMTS19	331	Q8TE59
AMESITVYQTVAHPG	UROS	161	P10746
SDYNITLTVMDHGTP	PCDHGA5	416	Q9Y5G8
MYTLVSVPHGNDIAS	ITPR2	351	Q14571
QTPTIMGSYLGVAHQ	NUP205	471	Q92621
EMTGSSVFDYIHPGD	NPAS1	176	Q99742
HQLGEGESYSMPTAF	NR4A1	216	P22736
ISASSAGPEMYEIHT	ARHGEF28	1156	Q8N1W1
LIMSGYSPEHDVSGI	AP1G1	226	O43747
GAMVNATDYHGATPL	ANKRD27	486	Q96NW4
TYTTGGSLDVPHIIM	ANKS1B	981	Q7Z6G8
THSRTDGIQMPYGDI	MPPED2	66	Q15777
NMEATSSEYSPIPGH	MUC16	4251	Q8WXI7
ITNLQYGEDMGHPGS	MUC16	12396	Q8WXI7
LHGAMYAPGEVTIAA	MUC6	361	Q6W4X9
GYHDNPTLEVMETSS	PODXL	506	O00592
PHSQEGDTLMATTYA	OR10H2	266	O60403
PSAATAGTGAIHMEY	GLI3	256	P10071
TGQHMSIIYEETNTP	LAMA3	1561	Q16787
TPTEGMINLYGAHTF	MGAM2	246	Q2M2H8
LTEAYGVPDASAHSM	SMPDL3B	361	Q92485
ITFLSIGYGDMVPHT	KCNN1	326	Q92952
SMGPVAHSVEYSIAD	CSRNP3	301	Q8WYN3
FVEHGPYVVTSNMTL	CPVL	121	Q9H3G5
MEISHTFTDYGPGVR	FBXO2	251	Q9UK22
YTTGTESLVGAEHAM	PCLO	2806	Q9Y6V0
PVHIDVGGHMYTSSL	KCTD1	31	Q719H9
MSGDGATEQAAEYVP	CSTF3	1	Q12996
YGSPEGQDTMTHNSL	GALNT11	386	Q8NCW6
AVEHGIPTDMGYAVA	NDST1	416	P52848
GETMTNDYVVHGPAS	LRP6	1406	O75581
VGYGEPSDQADVVMS	HSDL2	356	Q6YN16
VPEHQLGTAYGFMQS	MFSD1	381	Q9H3U5
SYDLGSGDTHTMIPT	LAMA2	2826	P24043
ISMTTVGYGDTHPVT	KCNS3	366	Q9BQ31
AHMVTLDYTVQVPGA	GNMT	216	Q14749
QGPSVTDLEMPHYST	PTPRZ1	701	P23471
HQETPVYLGATAGMR	ENTPD1	121	P49961
SHTLQSMYGCDVGPD	HLA-B	116	P01889
MGPVVHEVSDSQAGS	PCNT	1756	O95613
AGIHYVEAVFSMGPV	KIR3DX1	171	Q9H7L2
EHVGMEPLQFDYSGT	PUM1	351	Q14671
NGLEPVTYHRGQEMA	RHOD	146	O00212
IGNVHPVGSYESSEM	CCSER2	521	Q9H7U1
HFSISPEEGYITSGM	HYDIN	4571	Q4G0P3
MVSVLQHPEGGYAIA	ATG7	591	O95352
SYMPVIDVFSGHQNG	C2CD3	931	Q4AC94
NEEPSGLYQTVMSHS	DNAH3	66	Q8TD57
HMPSYGTQTLEGGVE	EGF	1166	P01133
TSLYASPSMVHEGVA	ERN1	291	O75460
VFGHSSGPMVEKYSV	FUNDC1	36	Q8IVP5
PTSATMGQLYEDSHE	GABARAPL3	86	Q9BY60
QHVPGYIDMVSTFGS	HOXD13	201	P35453
YIDMVSTFGSGEPRH	HOXD13	206	P35453
GHDVVEPGSYVQMFP	ABCA2	676	Q9BZC7
AHYSVSVNEDRPMGS	CELSR3	861	Q9NYQ7
ALESDYAGPGDTMQV	CYLD	211	Q9NQC7
YGPDHQLTEVGTMNI	BCAT2	256	O15382
NISGGPMTYSHRLEE	CA10	116	Q9NS85
GQTTDGTEPSHMHYA	GALC	106	P54803
NESSMPHSVIVYRDG	PIWIL3	711	Q7Z3Z3
HISPDQVPVEYGGTM	SEC14L2	231	O76054
LYPESHGIVGNSMYD	ENPP2	221	Q13822
HGIVGNSMYDPVFDA	ENPP2	226	Q13822
MTDTGQPHSEADYTL	CNTNAP3B	766	Q96NU0
YHEPSTIGSMALTEG	FAM126B	136	Q8IXS8
DGPGVKVQEYHIMSS	FANCD2	1046	Q9BXW9
SFKMDVGTVYSQPEH	OTOF	336	Q9HC10
ASYVAITGAVMHIPS	OR6A2	221	O95222
GQTEGYMAEGSEPET	PRUNE2	1151	Q8WUY3
YMGTESQGSAAAEPE	MIA3	886	Q5JRA6
SMVVHSSYDEIEGGG	SEC24A	256	O95486
QYGAVPGSSSQMSVH	TBX15	586	Q96SF7
MDSGDGVTHTVPIYD	POTEJ	816	P0CG39
MSESGHSQPGLYGIE	SMG9	1	Q9H0W8
EYGSTSSIDVQGMPE	SIPA1L3	201	O60292
SHGSESDYIVMPNIL	SCARB1	126	Q8WTV0
TVIPTGAYGQVAHSM	TANC2	1626	Q9HCD6
VEGVYSMEGSIVHLP	SPTLC3	306	Q9NUV7
IIYSMHVETGPNGEQ	NOL4	111	O94818
SPSLTMDSQYETGHI	SPTBN5	31	Q9NRC6
MAIYVNPFGGSHSES	BRINP2	586	Q9C0B6
SPVGSEISMQYRHDG	MLLT10	536	P55197
VNHPNYGTVDMTTGI	SLC7A14	506	Q8TBB6
YHMDNSLPIISSGSE	SHC4	596	Q6S5L8
GLNSTDHMVPDTESY	XIRP2	3101	A4UGR9
ERYGNITLPMSHAGT	RNF149	141	Q8NC42
PGTDIGISSLHMVGY	USPL1	16	Q5W0Q7
MSGEATVLAYHAPEE	ZSCAN30	1	Q86W11
GSHGVYESICNGVPM	UGT1A10	371	Q9HAW8
YDMQHTPTPIGDETE	MIOS	296	Q9NXC5
SVYATMGDHENRSPV	SPEN	1906	Q96T58
DSVTNPGQYVLTGMH	SHC2	511	P98077
PSYVQHIMGDIFSQG	UROC1	431	Q96N76
LENMSTGYHLGSPTA	PATJ	1771	Q8NI35
APVHIDVGGHMYTSS	KCTD15	56	Q96SI1
EYGMVHVVSQAGGPE	SPPL2B	26	Q8TCT7
HSEPLQVVEMYSSGG	TMEM131	236	Q92545
YTPTHEGGLEMQFRV	TNC	656	P24821
YSHADLAGVPLTGMN	TIMM23B	26	Q5SRD1
TDPENTDYTMEHGAT	YJU2	91	Q9BW85
MDSGPVYHGDSRQLS	TET3	136	O43151
GSHGVYESICNGVPM	UGT1A9	371	O60656
PGPSYSSSEQVHVTM	TOPORS	421	Q9NS56
THMEYGLFEDVTQPG	ZZEF1	2876	O43149
SPYGEADGEVAMVTS	SOX5	21	P35711
SEPMYTISDGIVQQH	TRPC5	861	Q9UL62
RESSLQYHSGMGTVE	TBX4	526	P57082
VAEYAVEMPHSSVGG	ZNF148	361	Q9UQR1
QPDDIGAHMNVGRTY	TMTC3	476	Q6ZXV5
PGSSQHYGAMRTVTE	XIRP1	1756	Q702N8
YDDTVKINSMGGDHP	ZNF318	276	Q5VUA4
YSHADLAGVPLTGMN	TIMM23	26	O14925
SHYIMPVGVEGAGAA	ZP4	101	Q12836
GSHGVYESICNGVPM	UGT1A7	371	Q9HAW7
GSHGVYESICNGVPM	UGT1A8	371	Q9HAW9